secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001140361-26-013481
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics enters change-in-control bonus agreements with four top executives
--------------------------------------------------------------------------------

- Agreements cover CEO Dr. George Magrath, CFO Robert Gagnon, COO Joseph Schachle, CS&DO Dr. Ashwath Jayagopal.
- Each agreement provides a gross-up payment for any excise tax under Section 4999 of the Code triggered by change of control.
- Agreements were entered into on April 1, 2026; form filed as Exhibit 10.1.
- Gross-up is designed to put executives in the same after-tax position as if the excise tax had not applied.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126013481/0001140361-26-013481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126013481/ef20069654_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-013481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer